William J Peppard1, Nathan A Ledeboer2. 1. Critical Care Pharmacist & Director of Critical Care Pharmacy Residency, Froedtert Hospital , Milwaukee, Wisconsin. 2. Associate Professor of Pathology, Medical College of Wisconsin , Milwaukee, Wisconsin . ; Medical Director, Clinical Microbiology, Froedtert Hospital and Dynacare Laboratories , Milwaukee, Wisconsin .
Abstract
PURPOSE: The polymerase chain reaction (PCR) test has higher sensitivity and a faster turnaround time than the enzyme immunoassay (EIA) for identification of Clostridium difficile, although the clinical implications of these variables are not well described. METHODS: Inpatients with a negative EIA (n = 79) or PCR (n = 87) test were retrospectively evaluated. Patients were excluded if they had a positive EIA or PCR test during the same hospitalization or if they were currently receiving treatment for C. difficile infection (CDI) prior to admission. The primary outcome was empiric CDI antibiotic duration of therapy associated with each test method. RESULTS: Empiric CDI antibiotic duration of therapy was 2.31 (95% confidence interval [CI], 1.48-3.15) days for the EIA group and 0.88 (0.45-1.33) days for the PCR group (P = .007). Number of diagnostic laboratory tests performed per patient were 2.73 (2.64-2.83) and 1.16 (1.04-1.28) tests, respectively (P < .001). CONCLUSION: Use of the PCR test to rule out CDI was associated with reduced duration of empiric CDI antibiotic therapy and fewer diagnostic laboratory tests performed per patient. When combined with fewer diagnostic laboratory tests performed per patient and shorter duration of contact isolation, the higher acquisition cost of the PCR test was offset, resulting in cost neutrality. These findings provide additional data to support the routine use of the PCR test.
PURPOSE: The polymerase chain reaction (PCR) test has higher sensitivity and a faster turnaround time than the enzyme immunoassay (EIA) for identification of Clostridium difficile, although the clinical implications of these variables are not well described. METHODS: Inpatients with a negative EIA (n = 79) or PCR (n = 87) test were retrospectively evaluated. Patients were excluded if they had a positive EIA or PCR test during the same hospitalization or if they were currently receiving treatment for C. difficileinfection (CDI) prior to admission. The primary outcome was empiric CDI antibiotic duration of therapy associated with each test method. RESULTS: Empiric CDI antibiotic duration of therapy was 2.31 (95% confidence interval [CI], 1.48-3.15) days for the EIA group and 0.88 (0.45-1.33) days for the PCR group (P = .007). Number of diagnostic laboratory tests performed per patient were 2.73 (2.64-2.83) and 1.16 (1.04-1.28) tests, respectively (P < .001). CONCLUSION: Use of the PCR test to rule out CDI was associated with reduced duration of empiric CDI antibiotic therapy and fewer diagnostic laboratory tests performed per patient. When combined with fewer diagnostic laboratory tests performed per patient and shorter duration of contact isolation, the higher acquisition cost of the PCR test was offset, resulting in cost neutrality. These findings provide additional data to support the routine use of the PCR test.
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: Joan Vinski; Mary Bertin; Zhiyuan Sun; Steven M Gordon; Daniel Bokar; James Merlino; Thomas G Fraser Journal: Infect Control Hosp Epidemiol Date: 2012-03-21 Impact factor: 3.254
Authors: Margaret M Guinta; Kristen Bunnell; Amanda Harrington; Susan Bleasdale; Larry Danziger; Eric Wenzler Journal: Ann Clin Microbiol Antimicrob Date: 2017-12-04 Impact factor: 3.944
Authors: Pil Hun Song; Jung Hwa Min; You Sun Kim; Soo Yeon Jo; Eun Jin Kim; Kyung Jin Lee; Jeonghun Lee; Hyun Sung; Jeong Seop Moon; Dong Hee Whang Journal: Intest Res Date: 2018-01-18